Chemspec International Ltd 

(Public, NYSE:CPC)   Watch this stock   
Find more results for CPC
Nov 6, 2009
Q3 2009 Chemspec International Limited Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 23.75% 33.65%
Operating margin 28.79% 31.28%
EBITD margin - 33.83%
Return on average assets 18.04% 40.28%
Return on average equity 22.70% 56.63%
Employees 1,247 -

Address

399 Park Avenue
New York, NY 10043
United States - Map
+1-212-8166690 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Chemspec International Ltd discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Chemspec International Ltd discussions

  View all discussions »

Description

Chemspec International Limited (Chemspec) is a China-based contract manufacturer of engineered specialty chemicals. The Company manufactures specialty chemicals, which are engineered chemicals used as building blocks in the manufacture of advanced chemicals or to enhance the performance of the end products manufactured by its end users in various industries, including electronics, pharmaceuticals and agrochemicals. In manufacturing specialty chemicals for its customers, the Company also provides process design and process development services. Chemspec sells its specialty chemicals directly to end users that incorporate them into their products and to trading companies that then sell its products to final end users. It also assists certain of its long-term customers to source specialty chemicals from other producers in China. On February 2, 2008, the Company acquired 80% interest in Jiangsu Wei Er Chemicals Co., Ltd. (Jiangsu Wei Er).

Officers and directors

Jianhua Yang
Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation - Reuters
Bing Zhu
Chief Financial Officer
Age: 44
Bio & Compensation - Reuters
Yunhung Tang
Executive Vice President - Marketing and Research and Development, Director
Age: 65
Bio & Compensation - Reuters
Peter H. Shu
Senior Vice President - Business Development
Bio & Compensation - Reuters
Xiaosong Yang
Vice President - Marketing
Age: 36
Bio & Compensation - Reuters
Wujun Yang
Vice President
Age: 57
Bio & Compensation - Reuters
Zixin Wang
Vice President
Age: 31
Bio & Compensation - Reuters
Yunlong Yuan
Vice President
Age: 35
Bio & Compensation - Reuters
Jinhua Chen
Vice President - Process Research and Development
Bio & Compensation - Reuters
Yuelie Lu
Vice President - Pharmaceutical Business Development
Bio & Compensation - Reuters